symbol,statement_type,period_end,line_item,value
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,7821500000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,240000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-1203000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,End Cash Position,1150900000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,882200000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,-100000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,268800000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-5796800000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-96200000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-2370400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,-2370400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,240000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,240000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-3439200000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,-3439200000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-2958900000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,45400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,100000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-1812500000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,10554400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-12366900000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,-227100000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of Intangibles,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,-227100000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-964800000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,11100000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-975900000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,9024500000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-2006700000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,71800000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Payable,834200000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-264400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-498000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,51500000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,549000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,42900000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,1710400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Depreciation,1710400000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-322200000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,56000000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-2100000.0
JBCHEPHARM.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,8873900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,5392600000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-1790000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,0.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,199900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-2613600000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,End Cash Position,882200000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,769300000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,-200000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,113100000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-3854800000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-442100000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-1569900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,-1569900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,199900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,199900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-1915900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-125900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-1790000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-1790000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,0.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-4038300000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,40800000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,0.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-1475200000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,7213300000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-8688500000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,-1345000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of Intangibles,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,-1345000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-1258900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,9700000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-1268600000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,8006200000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-1324800000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-56300000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Payable,1380000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-720300000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-716000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,387000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,419700000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,114000000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,1383200000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Depreciation,1383200000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-327500000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-105900000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,1700000.0
JBCHEPHARM.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,7515100000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-1393349000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-872500000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,6086268000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,84827000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-7649470000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,End Cash Position,769344000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,565441000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,286000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,203617000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,3565380000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,-55798000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-322292000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-1275926000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-1275926000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,84827000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,84827000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,5231596000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,17828000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,5213768000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-872500000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,6086268000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-9617884000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,21801000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,30000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-1998604000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,5570105000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-7568709000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,-6923784000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of Intangibles,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,-6923784000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-717327000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,8359000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-725686000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,6256121000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-954787000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-299202000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Payable,323496000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-205232000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-417466000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,311938000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Stock Based Compensation,693734000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,35470000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,1144069000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Depreciation,1144069000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-69028000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-158327000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-72000.0
JBCHEPHARM.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,5552326000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-5366500000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-7067900000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,End Cash Position,565400000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,224700000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,340700000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-1383900000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-24600000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-1275600000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-1275600000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-3300000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-3300000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,23200000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,9400000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,7003900000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,12088600000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-5084700000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-6439200000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of Intangibles,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-6439200000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-550900000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,77800000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-628700000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,1701400000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-1346100000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-3024200000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Payable,529300000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-625100000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-2928400000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,10300000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Stock Based Compensation,626500000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,0.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,726600000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Depreciation,726600000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,954000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-350400000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,35200000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-25500000.0
JBCHEPHARM.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,5049000000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,0.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,3223000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,0.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,3223000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,-2260000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,-85000000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,-85000000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of Intangibles,215675000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Stock Based Compensation,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Depreciation,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,-166997000.0
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
JBCHEPHARM.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
